Efficacy of Acupuncture Is Noninferior to Nicotine Replacement Therapy for Tobacco Cessation Results of a Prospective, Randomized, Active-Controlled Open-Label Trial

被引:19
作者
Wang, Ying-ying [1 ]
Liu, Zhao [2 ,3 ]
Wu, Yuan [4 ]
Yang, Li [1 ]
Guo, Lang-tao [5 ]
Zhang, Hao-bin [6 ]
Yang, Jin-sheng [1 ]
机构
[1] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing 100070, Peoples R China
[2] China Japan Friendship Hosp, Tobacco Med & Tobacco Cessat Ctr, Beijing, Peoples R China
[3] WHO Collaborating Ctr Tobacco Cessat & Resp Dis P, Beijing, Peoples R China
[4] China Assoc Acupuncture & Moxibust, Beijing, Peoples R China
[5] Xian Encephalopathy Hosp Tradit Chinese Med, Xian, Shaanxi, Peoples R China
[6] Shaanxi Univ TCM, Coll Acupuncture & Moxibust, Xian, Shaanxi, Peoples R China
关键词
acupuncture; nicotine replacement therapy; randomized controlled trial; tobacco cessation; SMOKING-CESSATION;
D O I
10.1016/j.chest.2017.11.015
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: We designed and conducted this multicenter randomized active-controlled open-label trial to evaluate the efficacy of acupuncture, auricular point pressing, and nicotine replacement therapy (NRT) on tobacco cessation in the Chinese population. METHODS: This randomized controlled trial was conducted in seven hospitals in China between October 2013 and February 2016. Eligible participants were recruited and randomly assigned to receive acupuncture or auricular point pressing or NRT via a central randomization system with a 1:1:1 ratio. All treatment was given for a total of 8 weeks, and follow-up visit was at 16 weeks. The primary outcome measure was carbon monoxide (CO)-confirmed 24-h point abstinence rate (<10 parts per million), 24 weeks after quit day. RESULTS: A total of 300 participants were recruited and 195 participants finished, with a dropout rate of 35.00%. Two cases of adverse events in the acupuncture group and 2 cases in the NRT group were observed. The CO-confirmed 24-h point abstinence rate was 43.00% at 24 weeks in the acupuncture group, which was similar to 44.00% in the NRT group (P > .05), but significantly higher than the 30.00% in the auricular point group (P < .05). At 24 weeks, the Fagerstrom Nicotine Dependence Test and the Minnesota Nicotine Withdrawal Scale scores in the acupuncture group were significantly lower than those in the auricular point group and in the NRT group (P < .05). Kaplan-Meier analysis showed the time to relapse for acupuncture (44.12 days) was insignificantly longer than NRT (41.18 days), but significantly longer than auricular point pressing (29.53 days). CONCLUSIONS: We found acupuncture was safe and a possible treatment for tobacco cessation, but it requires further study to establish its role.
引用
收藏
页码:680 / 688
页数:9
相关论文
共 50 条
  • [31] Outcomes of a Comprehensive Mobile Smoking Cessation Program With Nicotine Replacement Therapy in Adult Smokers: Pilot Randomized Controlled Trial
    Marler, Jennifer D.
    Fujii, Craig A.
    Utley, MacKenzie T.
    Balbierz, Daniel J.
    Galanko, Joseph A.
    Utley, David S.
    JMIR MHEALTH AND UHEALTH, 2022, 10 (11):
  • [32] Effect of a Low Salt Diet on the Progression of Chronic Kidney Disease: A Prospective, Open-Label, Randomized Controlled Trial
    Trakarnvanich, Thananda
    Chailimpamontree, Worawon
    Kantachuvesiri, Surasak
    Anutrakulchai, Sirirat
    Manomaipiboon, Basmon
    Ngamvitchukorn, Tanun
    Suraamornkul, Swangjit
    Trakarnvanich, Thanphisit
    Kurathong, Sathit
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2024, 15
  • [33] Efficacy and safety of Reyanning mixture in patients infected with SARS-CoV-2 Omicron variant: A prospective, open-label, randomized controlled trial
    Xu, Xiangru
    Zhou, Shuang
    Chen, Caiyu
    Li, Jinhua
    Wu, Hongze
    Jin, Guoqiang
    Zhou, Jing
    Wang, Gang
    Cao, Min
    Sun, Ding
    Zhang, Wen
    Peng, Wei
    Pu, Yuting
    Sun, Yuting
    Fang, Bangjiang
    Xu, Jianguang
    PHYTOMEDICINE, 2023, 108
  • [34] Efficacy and safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage: A randomized, controlled, open-label, blinded endpoint trial (NESICH)
    Wang, Long
    Zhou, Tengyuan
    Wang, Pangbo
    Zhang, Shuixian
    Yin, Yi
    Chen, Lin
    Duan, Haijun
    Wu, Na
    Feng, Hua
    Hu, Rong
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (05) : 587 - 592
  • [35] Acupuncture Treatment of Delirium in Older Adults Hospitalized in Internal Medicine Departments: An Open-Label Pragmatic Randomized-Controlled Trial
    Levy, Ilana
    Gavrieli, Sagi
    Hefer, Talia
    Attias, Samuel
    Schiff, Ariel
    Oliven, Ron
    Wisberg-Levi, Shikma
    Hanchinsky, Rina
    Schiff, Elad
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2022, 35 (03) : 333 - 343
  • [36] Acupuncture in the treatment of acute toxicity during and after head and neck cancer radiotherapy: Interim analysis of randomized prospective open-label trial
    Dymackova, Radana
    Kazda, Tomas
    Slavik, Marek
    Selingerova, Iveta
    Slampa, Pavel
    Slama, Ondrej
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (04): : 454 - 460
  • [37] Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis Results of a randomized, open label, active-controlled trial in healthy adult volunteers in India
    Sudarshan, Mysore Kalappa
    Narayana, Doddabele Hanumanthaiah Ashwath
    Madhusudana, Shampur Narayan
    Holla, Ramesh
    Ashwin, Belludi Yajaman
    Gangaboraiah, Bilagumba
    Ravish, Haradanahalli S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (08) : 1077 - 1081
  • [38] Efficacy and safety of two Ayurvedic dosage forms for allergic rhinitis: Study protocol for an open-label randomized controlled trial
    Dahanayake, Jeevani Maheshika
    Perera, Pathirage Kamal
    Galappaththy, Priyadarshani
    Samaranayake, Dulani
    TRIALS, 2020, 21 (01)
  • [39] Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy Protocol for an open-label randomized controlled clinical trial
    Geng, Chanyu
    Li, Qiang
    Pu, Lei
    Yang, Hongling
    Li, Guisen
    Feng, Yunlin
    MEDICINE, 2022, 101 (06) : E28842
  • [40] Efficacy of Incontinence-Associated Dermatitis Intervention for Patients in Intensive Care: An Open-Label Pilot Randomized Controlled Trial
    Coyer, Fiona
    Campbell, Jill
    Doubrovsky, Anna
    ADVANCES IN SKIN & WOUND CARE, 2020, 33 (07) : 375 - 382